Bayesian Capital Management’s Invitae Corporation NVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107,135
Closed -$199K 1165
2022
Q4
$199K Buy
+107,135
New +$262K 0.03% 603
2020
Q1
Sell
-21,700
Closed -$350K 1024
2019
Q4
$350K Buy
+21,700
New +$384K 0.06% 389
2019
Q2
Sell
-14,261
Closed -$334K 710
2019
Q1
$334K Sell
14,261
-6,039
-30% -$107K 0.06% 370
2018
Q4
$225K Buy
20,300
+5,700
+39% +$73.9K 0.05% 488
2018
Q3
$244K Buy
+14,600
New +$166K 0.04% 508

Other funds holding NVTA

Bayesian Capital Management's NVTA Position: Q1 2023 in Review

Bayesian Capital Management sold out of Invitae Corporation (NVTA) in Q1 2023, closing a stake of 107,135 shares — an estimated $199K sold.

Bayesian Capital Management first reported a position in NVTA in Q3 2018 and held it in 5 quarters. The position peaked at $350K in Q4 2019. 272 funds tracked by Wall St. Rank hold NVTA as of Q1 2023.

  • Bayesian Capital Management reported no remaining Invitae Corporation position as of Q1 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 107,135 Invitae Corporation shares in Q1 2023, an estimated $199K.
  • Bayesian Capital Management first reported a position in Invitae Corporation in Q3 2018 and held it in 5 quarters.
  • Bayesian Capital Management's Invitae Corporation position peaked at $350K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held Invitae Corporation as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.